JPMorgan lowered the firm’s price target on iRhythm (IRTC) to $175 from $215 and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target lowered to $185 from $225 at Oppenheimer
- iRhythm price target lowered to $160 from $170 at Evercore ISI
- iRhythm price target raised to $255 from $254 at Needham
- iRhythm price target lowered to $180 from $198 at Canaccord
- iRhythm: Strong Q1 Beat, Expanding Zio Adoption and Next-Gen Algorithm Catalyst Underpin Outperform Rating and 2026 Upside